Mental Retardation, Autosomal Dominant 1
|
0.610 |
Biomarker
|
disease |
BEFREE |
Both MRD0+/MRD1+ and MRD0+/MRD1- patients had a significantly worse EFS (p = 0.0001) than those with undetectable MRD at both MRD0 and MRD1.
|
26449287 |
2017 |
Mental Retardation, Autosomal Dominant 1
|
0.610 |
GeneticVariation
|
disease |
UNIPROT |
Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.
|
22726846 |
2012 |
Mental Retardation, Autosomal Dominant 1
|
0.610 |
GeneticVariation
|
disease |
UNIPROT |
Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation.
|
17847001 |
2007 |
Mental Retardation, Autosomal Dominant 1
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
Mental Retardation, Autosomal Dominant 1
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Bipolar Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
We identified heterogeneous, multisystem pathogenic effects of MBD5 disruption and characterized the associated spectrum of psychopathology, including the novel finding of anxiety and bipolar disorder in multiple patients.
|
23587880 |
2014 |
Bipolar Disorder
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We identified heterogeneous, multisystem pathogenic effects of MBD5 disruption and characterized the associated spectrum of psychopathology, including the novel finding of anxiety and bipolar disorder in multiple patients.
|
23587880 |
2014 |
Atrial Fibrillation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
Paroxysmal atrial fibrillation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
Persistent atrial fibrillation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
familial atrial fibrillation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Multi-ethnic genome-wide association study for atrial fibrillation.
|
29892015 |
2018 |
2q23.1 microdeletion syndrome
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype.
|
19809484 |
2010 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
Exome sequencing disclosed a novel heterozygous pathogenic frameshift mutation of MBD5 that was considered to be causative for the combination of intellectual disability, treatment-resistant epilepsy and autism.
|
31290275 |
2019 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
Diagnostic exome sequencing identifies a heterozygous MBD5 frameshift mutation in a family with intellectual disability and epilepsy.
|
28807762 |
2017 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
BEFREE |
To further elucidate the involvement of MBD5 in ID, we sequenced ten coding, five non-coding exons and an evolutionary conserved region in intron 2, in a selected cohort of 78 subjects with a phenotype reminiscent of 2q23.1 microdeletion syndrome.
|
23422940 |
2013 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
Notably a deletion in a psychotic VCFS patient at 2q23.1 hit the gene MBD5 which when deleted gives rise to intellectual disability, epilepsy, and autistic features.
|
23335482 |
2013 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
BEFREE |
MBD5, the only gene deleted in all patients, is considered to be responsible for ID and epilepsy.
|
22407754 |
2012 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
Partial or complete deletion of MBD5 was associated with haploinsufficiency of mRNA expression, intellectual disability, epilepsy, and autistic features.
|
21981781 |
2011 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
HPO |
|
|
|
Seizures
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.
|
22085995 |
2012 |
Seizures
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.
|
22659271 |
2012 |
Seizures
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.
|
19904302 |
2010 |
Seizures
|
0.130 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe intellectual disability
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Phenotypic features of 2q23.1 deletion or disruption of MBD5 gene include severe intellectual disability, seizure, significant speech impairment, sleep disturbance, and autistic-like behavioural problems.
|
28807762 |
2017 |
Sleep disturbances
|
0.110 |
Biomarker
|
phenotype |
BEFREE |
MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.
|
25271084 |
2015 |